<DOC>
	<DOCNO>NCT01524640</DOCNO>
	<brief_summary>This randomize , double blind , placebo control trial confirm safety determine immune response kill oral cholera vaccine healthy adult child Ethiopia .</brief_summary>
	<brief_title>Bridging Study Killed Oral Cholera Vaccine Ethiopia</brief_title>
	<detailed_description>This study serve bridge trial evaluate safety immunogenicity two dose regimen WC-OCV ( Shanchol® ) Ethiopian population . In order ass whether bivalent kill oral cholera vaccine may use safely among risk cholera , need determine safety immunogenicity kill oral cholera vaccine . The vaccine evaluate large number human subject India Vietnam , Bangladesh , demonstrate safety , immunogenicity , clinical protective efficacy . Though expect vaccine act differently Ethiopian population , aim confirm presumptive understanding two dose WC-OCV safe immunogenic healthy volunteer one year ( exclusive pregnant woman ) . Findings study pave way possible use kill whole cell oral cholera vaccine endemic outbreak setting large scale .</detailed_description>
	<mesh_term>Cholera</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Male female adult age 18 year ; child age 1 17 year available followup visit specimen collection . The subject able continue study next 4 week The subject ( parent/guardian ) willing provide 3 blood sample 2 . For female reproductive age , nonpregnant ( determined urine pregnancy test ) . 3 . Written inform consent obtain subject parents/guardians , write assent obtain child age 12 17 year . 4 . Healthy subject determine : Medical history Physical examination Clinical judgment investigator 1 . Ongoing chronic recur illness may cause systemic symptom judge investigate physician . 2 . Ongoing acute illness . 3 . For female reproductive age : Pregnancy ( females plan become pregnant study period ; determine verbal screen ) 4 . Immunocompromising condition chronic systemic steroid therapy 5 . Diarrhea ( 3 loose/more watery stool within 24hour period ) within 6 week prior enrollment 6 . Intake antidiarrhea medicine past week 7 . Abdominal pain cramp , loss appetite , nausea , vomit past 24 hour 8 . Temperature ≥38ºC ( oral axillary ) warrant deferral vaccination pending recovery subject 9 . Previous hypersensitivity formaldehyde . 10 . Receipt immunoglobulin blood product past 3 month 11 . Receipt oral cholera vaccine past three year 12 . Any potential subject currently participate participate within next six month another clinical trial 13 . Positive screen urine pregnancy test female great 12 year age</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>oral cholera vaccine</keyword>
	<keyword>safety immunogenicity</keyword>
	<keyword>bridging study</keyword>
	<keyword>ethiopia</keyword>
</DOC>